Cart is empty Intravenous (IV) injection is a common route for medical treatment worldwide as it induces rapid effects and allows continuous administration of medication by directly injecting drugs into the blood vessel. However, medical IV needles, made of hard materials such as stainless steel or plastic that do not mechanically match the soft biological tissues of the body, can cause critical problems in health care settings, starting from minor tissue damages in the injection sites to serious inflammation.
A high-risk antiphospholipid antibody profile matters in pediatric patients with antiphospholipid syndrome
A new study by Hospital for Special Surgery (HSS) investigators has found that an initial high-risk antibody profile for antiphospholipid syndrome (APS) tended to remain high in pediatric patients. The results were presented in a poster session at American College of Rheumatology (ACR) Convergence 2023.
Q&A: Can virtual reality help people eat a healthier diet?
With heart disease and diabetes—which can be caused or worsened by poor diet—among the leading causes of death and illness for adults in the United States, researchers in the Penn State College of Health and Human Development are studying influences on human eating behavior.
Landlord, private bailiff sued for breach of tenancy agreement
By LUCY PHIRI
A LUSAKA landlord and his private bailiffs have been dragged to Lusaka High court by a tenant for breach of tenancy agreement as well as for not following a laid down procedure by a bailiff who was authorised to execute a warrant of distress.
This content is locked
This is exclusive material. To read full story, click on register and choose one of the premium subscriptions to view this content. Login if you are already a premium user.
Mozambique faces alarming multidrug-resistant tuberculosis epidemic
With one of the highest tuberculosis (TB) incidences (368 cases/100,000 population) in the African region, Mozambique is particularly affected by the TB epidemic. Drug-resistant TB is also a major problem, with 4,800 new cases of multidrug resistant (MDR)/rifampicin-resistant TB in the country estimated in 2021.
Consumer health: Recognizing the signs of pneumonia
Pneumonia causes more than 1 million hospitalizations and 50,000 deaths per year in the U.S., according to the American Lung Association.
Your reaction matters: The role of antibodies in COVID-19 response
Efforts to contain the COVID-19 pandemic have largely focused on vaccine development and deployment. But how exactly do our immune systems respond to COVID-19 vaccines? The major response occurs in one of two ways: the production of antibodies that bind to the receptor-binding domain (RBD) or the production of antibodies that bind to the N-terminal domain (NTD) of the coronavirus viral spike protein.
A new RSV shot could help protect babies this winter—if they can get it in time
A RSV new therapy for infants, called nirsevimab, started shipping in September. By mid-October, demand for nirsevimab, sold under the brand name Beyfortus, had already outstripped supply, according to the pharmaceutical company Sanofi, which developed the drug with AstraZeneca.
Trial shows a single dose of an experimental therapy reduces lipoprotein(a) by more than 94% for nearly a year
Findings from a Phase I trial reported by a Cleveland Clinic physician show that a single dose of an experimental therapy produced greater than 94% reductions in blood levels of lipoprotein(a), a key driver of heart disease risk, with the results lasting for nearly a year.
Blood thinner apixaban found to prevent strokes in patients with device-detected atrial fibrillation
The widely available blood thinner apixaban substantially reduced stroke in at-risk patients with a type of atrial fibrillation only detectable by a pacemaker or other implanted cardiac electronic device, a global study has found.